GGrantIndex
← Leaderboards

Robert J Linhardt

University Of Iowa

Google Scholar ↗PubMed ↗ORCID ↗
$15,064,370
Attributed
$23,155,350
Total exposure
15
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2005–24
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$23,155,350 · 15

By mechanism

R01$18,246,962 · 8
RF1$2,595,120 · 1
RC2$1,273,134 · 1
R41$400,000 · 1
S10$343,946 · 1
R21$253,188 · 1

Top collaborators

Others in their field

Top investigators on “Heparin”

Research focus

HeparinPolysaccharidesStructureOligosaccharidesBaseFibroblast Growth FactorGlycosaminoglycansEnzymesHeparitin SulfateProteoglycanComplexLaboratoriesCellsPreventBiologicalDisaccharidesBinding ProteinsChondroitin SulfatesLinkPharmaceutical PreparationsSugarAntithrombin IiiProteinsSurface Plasmon Resonance

Grant awards (56)

Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease$554,778
R01 · FY2024 · AG
Glycomics-driven diagnostics for Candida auris$253,188
R21 · FY2021 · AI · contact PI
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease$2,595,120
RF1 · FY2020 · AG
Biacore T200 Surface Plasmon Resonance Spectroscopy$343,946
S10 · FY2020 · OD · contact PI
Endothelial glycocalyx reconstitution during sepsis$663,178
R01 · FY2018 · HL
Endothelial glycocalyx reconstitution during sepsis$664,880
R01 · FY2017 · HL
Endothelial glycocalyx reconstitution during sepsis$666,703
R01 · FY2016 · HL
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$389,112
R01 · FY2016 · HL · contact PI
Endothelial glycocalyx reconstitution during sepsis$658,461
R01 · FY2015 · HL
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$383,385
R01 · FY2015 · HL · contact PI
Endothelial glycocalyx reconstitution during sepsis$697,032
R01 · FY2014 · HL
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$381,547
R01 · FY2014 · HL · contact PI
Development of a Bioengineered Heparin from a Non-Animal Source$697,259
R01 · FY2013 · HL · contact PI
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$419,533
R01 · FY2013 · HL · contact PI
Development of a Bioengineered Heparin from a Non-Animal Source$787,839
R01 · FY2012 · HL · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$268,606
R01 · FY2012 · GM · contact PI
2012 Proteoglycans Gordon Research Conference$13,000
R13 · FY2012 · AR · contact PI
Development of a Bioengineered Heparin from a Non-Animal Source$790,546
R01 · FY2011 · HL · contact PI
Stable Carbohydrate Libraries in Infectious Disease$376,964
R01 · FY2011 · AI · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$268,606
R01 · FY2011 · GM · contact PI
Development of a Bioengineered Heparin from a Non-Animal Source$798,864
R01 · FY2010 · HL · contact PI
Characterization of Anticoagulant Heparin and Related Polysaccharides$552,006
RC2 · FY2010 · HL
Stable Carbohydrate Libraries in Infectious Disease$380,772
R01 · FY2010 · AI · contact PI
An Artificial Golgi: Controlled GAG Synthesis and Screening$294,888
R01 · FY2010 · GM · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$271,319
R01 · FY2010 · GM · contact PI
2010 Proteoglycans Gordon Conference$30,000
R13 · FY2010 · AR · contact PI
Development of a Bioengineered Heparin from a Non-Animal Source$12,998
R01 · FY2010 · HL · contact PI
Development of a Bioengineered Heparin from a Non-Animal Source$797,935
R01 · FY2009 · HL · contact PI
Characterization of Anticoagulant Heparin and Related Polysaccharides$721,128
RC2 · FY2009 · HL
Stable Carbohydrate Libraries in Infectious Disease$384,618
R01 · FY2009 · AI · contact PI
Chemoenzymatic Synthesis of Glycosaminoglycan Oligos$359,542
R01 · FY2009 · HL · contact PI
An Artificial Golgi: Controlled GAG Synthesis and Screening$302,106
R01 · FY2009 · GM · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$289,310
R01 · FY2009 · GM · contact PI
Stable Carbohydrate Libraries in Infectious Disease$384,618
R01 · FY2008 · AI · contact PI
Chemoenzymatic Synthesis of Glycosaminoglycan Oligos$358,281
R01 · FY2008 · HL · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$248,643
R01 · FY2008 · GM · contact PI
Heparin Glycan Microarray for Screening$200,000
R41 · FY2008 · RR · contact PI
Stable Carbohydrate Libraries in Infectious Disease$407,068
R01 · FY2007 · AI · contact PI
Chemoenzymatic Synthesis of Glycosaminoglycan Oligos$357,064
R01 · FY2007 · HL · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$248,643
R01 · FY2007 · GM · contact PI
Heparin Glycan Microarray for Screening$200,000
R41 · FY2007 · RR · contact PI
Chemoenzymatic Synthesis of Glycosaminoglycan Oligos$381,529
R01 · FY2006 · HL · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$256,069
R01 · FY2006 · GM · contact PI
Sequencing the Polysaccharide Component of Proteoglycans$274,231
R01 · FY2005 · GM
SYNTHESIS OF GLYCOSAMINOGLYCAN OLIGOSACCHARIDES$251,610
R01 · FY2004 · HL
Glycosaminoglycan-Protein Interactions$257,250
R01 · FY2003 · HL
SYNTHESIS OF GLYCOSAMINOGLYCAN OLIGOSACCHARIDES$257,250
R01 · FY2003 · HL
Glycosaminoglycan-Protein Interactions$109,750
R01 · FY2003 · HL
Glycosaminoglycan-Protein Interactions$257,250
R01 · FY2002 · HL
SYNTHESIS OF GLYCOSAMINOGLYCAN OLIGOSACCHARIDES$257,250
R01 · FY2002 · HL
SEQUENCING THE POLYSACCHARIDE COMPONENT OF PROTEOGLYCANS$225,351
R01 · FY2002 · GM
Glycosaminoglycan-Protein Interactions$257,250
R01 · FY2001 · HL
SYNTHESIS OF GLYCOSAMINOGLYCAN OLIGOSACCHARIDES$257,250
R01 · FY2001 · HL
SEQUENCING THE POLYSACCHARIDE COMPONENT OF PROTEOGLYCANS$218,873
R01 · FY2001 · GM
SEQUENCING THE POLYSACCHARIDE COMPONENT OF PROTEOGLYCANS$212,584
R01 · FY2000 · GM
HEPARIN-PROTEIN/PEPTIDE INTERACTIONS$208,367
R01 · FY2000 · HL